Health News Releases

  • Today August 24
Intro of Dr. Yu-mi Jung of Magic Kiss dental clinic
March 20, 2019 17:59
Dr. Yu-mi Jung of Magic Kiss dental clinic has more scientific teeth contouring and gum forming techniques to complete the ‘Smile Line’ and correct ‘Gummy Smile’
‘Smile Line’ is a virtual line made by the upper and lower lips that reveal the front teeth when smiling. With everything about smiles, the author of Smile Design, and Dr. Jung, president of the Magic
March 19, 2019 11:40
SpeeDx Distribution Network Expands to the Middle East
SpeeDx Pty. Ltd. have announced signing new partners Al Zahrawi Medical Supplies LLC for distribution of ResistancePlus® and PlexPCR® tests across UAE, Saudi Arabia, Oman, Bahrain, and Qatar. “Al Z
March 19, 2019 11:05
Boehringer Ingelheim announces FDA and EMA regulatory submission for nintedanib in systemic sclerosis associated ILD
Boehringer Ingelheim has filed for regulatory approval of nintedanib in patients with systemic sclerosis associated interstitial lung disease (SSc-ILD) with the FDA and EMA. Nintedanib as an anti-fibr
March 18, 2019 17:25
Solasia Files New Medical Device Application for episil® in South Korea
Solasia Pharma K.K. (TOKYO:4597, Headquarters:Tokyo, Japan, President & CEO:Yoshihiro Arai, hereinafter “Solasia”), a specialty pharmaceutical company based in Asia, today officially announced that th
March 15, 2019 11:40
Octapharma Group Reports Strong Results for 2018
Commenting on the Group’s results, Octapharma CEO and Chairman Wolfgang Marguerre said: “In 2018, we continued to drive growth in many of our products. I am particularly pleased with the important reg
March 12, 2019 10:40
Celgene Submits Application to EMA for Ozanimod for the Treatment of Relapsing-Remitting Multiple Sclerosis
Celgene Corporation (NASDAQ:CELG) today announced that the Company has submitted a Marketing Authorization Application to the European Medicines Agency (EMA) for ozanimod for the treatment of adults w
March 11, 2019 11:10
Vedolizumab (Entyvio®) Achieves Superior Rates of Clinical Remission vs. Adalimumab (Humira®) in First Ever Head-to-Head Biologic Clinical Study in Ulcerative Colitis
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced results from the Phase 3b head-to-head VARSITY study which demonstrated that the gut-selective biologic vedolizumab
March 11, 2019 10:10
New ESMO Guidelines Include FOTIVDA®▼(tivozanib) Recommendation for Patients with Advanced Renal Cell Carcinoma
HEMEL HEMPSTEAD, England--(BUSINESS WIRE)-- EUSA Pharma (EUSA) welcomes the news that FOTIVDA®▼ (tivozanib) has been included in the new European Society of Medical Oncology (ESMO) clinical practice g
March 11, 2019 10:00
Galderma Presented Final Results from Phase 2b Study of Nemolizumab in Patients with Moderate-to-Severe Atopic Dermatitis at the 2019 American Academy of Dermatology Annual Meeting Late-Breaking Session
Galderma, Nestlé Skin Health’s medical solutions business, presented the final results from a Phase 2b dose-ranging study of nemolizumab, an investigational therapy in adult patients with moderate-to-
March 08, 2019 18:50
Mindray Signs Patient Safety Movement’s Open Data Pledge & Becomes 90th Company to Join to Improve Patient Safety
The Patient Safety Movement Foundation (PSMF) announced today that the global medical device developer and manufacturer Mindray has become the 90th company to sign the PSMF’s Open Data Pledge, demonst
March 08, 2019 17:40
ResMed Acquires HB Healthcare to Help Millions of Koreans Living with Sleep Apnea, Other Respiratory Conditions
ResMed (NYSE: RMD, ASX: RMD), a global leader in cloud-connected sleep and respiratory care devices in more than 120 countries, today announced that is has completed the acquisition of HB Healthcare (
March 08, 2019 16:55
Carestream Health to Sell Its Healthcare IT Business to Philips
Carestream Health has signed an agreement with Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, to sell its healthcare information systems (HCIS) business to Philips. Car
March 08, 2019 13:25
Impossible Foods Continues Asian Expansion in Singapore
Impossible Foods is launching its plant-based meat Thursday, 7 March, with a variety of dishes available at eight restaurants throughout Singapore -- one of the world’s most vibrant and discerning cul
March 05, 2019 17:00
Masimo Announces CE Marking of Pediatric Indication for Next Generation SedLine® Brain Function Monitoring
Masimo (NASDAQ: MASI) announced today the CE marking of Next Generation SedLine® brain function monitoring for pediatric patients (1-18 years of age). With this clearance, the benefits of Next Generat
February 27, 2019 11:05
Boehringer Ingelheim and GNA Biosolutions partner on emergency veterinary diagnostics development
Boehringer Ingelheim and GNA Biosolutions announce that they have entered into a research collaboration focused on the development of a rapid African swine fever (ASF) diagnostic test. The test would
February 26, 2019 20:00
LMD’s Smartphone-Integrated e-Checkup™ System Makes Medically-Accurate Personal Health Monitoring a Reality
Leman Micro Devices (LMD), the developer of regulated consumer healthcare products that is backed by major players within the mobile device industry, has announced that e-Checkup™ is now poised to be
February 26, 2019 11:40
New Case Series Investigates the Combined Use of Masimo SedLine® Brain Function Monitoring and O3® Regional Oximetry During Cardiac Surgery
Masimo (NASDAQ: MASI) announced today the findings of a series of four clinical cases, recently published in the Canadian Journal of Anesthesiology, in which researchers at the University of Montreal
February 25, 2019 09:50
Mundipharma EDO GmbH: US FDA grants Orphan Drug Designation for etoposide toniribate in relapsed/refractory biliary tract cancer
Mundipharma EDO GmbH, part of the Mundipharma network of independent associated companies, and Imbrium Therapeutics L.P., an operating subsidiary of Purdue Pharma L.P., today announced that the US FDA
February 21, 2019 16:00
ResMed and Fisher & Paykel Healthcare Announce Settlement of Global Patent Infringement Litigation
ResMed (NYSE: RMD, ASX: RMD), and Fisher & Paykel Healthcare (NZX: FPH, ASX: FPH) today announced an agreement to settle all outstanding patent infringement disputes between the companies in all venue
February 21, 2019 13:35
KCI Launches ABTHERA™ Therapy in Japan
KCI, an Acelity Company, today announced the launch of ABTHERA™ Open Abdomen Negative Pressure Therapy in Japan, expanding access to the Company’s surgical portfolio in the country. ABTHERA™ Therapy i
February 19, 2019 16:50
Boehringer Ingelheim and Lilly’s CAROLINA® cardiovascular outcome trial for Trajenta® meets primary endpoint of non-inferiority compared to glimepiride
Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) announced CAROLINA® (CARdiovascular Outcome study of LINAgliptin versus glimepiride in patients with type 2 diabetes) met its primary endpoin
February 19, 2019 13:45
Saudi Arabia Ministry of Health and Masimo Announce Automation of National Neonatal CCHD Screening Process Using Masimo Technology
Recently at Arab Health 2019, the Saudi Arabia Ministry of Health (MOH) and Masimo (NASDAQ: MASI) jointly announced the implementation of an automation solution designed to streamline the process of c
February 14, 2019 11:40
SpeeDx Develops Multiplex Test for Respiratory Viruses
SpeeDx Pty. Ltd. today announced submission of their PlexPCR® RespiVirus test to the Therapeutic Goods Administration (TGA). The company anticipates clearance in time for the Australian 2019 flu seaso
Dr. Yumi Jung is explaining gum and mouth condition to patients through digital scanning
February 13, 2019 09:50
Clean management of Laser Gum Bleaching with Dr. Yumi Jung of MAGIC KISS Dental Clinic in Korea
When someone mentions whitening (Bleaching), you will usually think of whitening of the teeth or face. But some people are worried about their black or dark gums. So, Dr. Yumi Jung, the chief denti
February 12, 2019 16:50
European Commission Approves ADCETRIS® (brentuximab vedotin) with AVD, the First New Treatment in Decades for Adults with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) today announced that the European Commission (EC) extended the current marketing authorization of ADCETRIS (brentuximab vedotin) to include tr
25 per page50 per page75 per page100 per page